Table 1b.

Anti-rotavirus immunogenicity evaluations including nutritional status as a predictor, 2006–202

Vaccine	Type of study	Year of publication	Country	Age group	Study setting	Rotavirus endpoint	Indicator of malnutrition	Key finding	Reference
Rotarix	Randomized trial	2016	Bangladesh	<6 months	Community	IgA (seroconversion)	Length-for-age	No association	(33)
							Weight-for-length	No association
Rotarix	Randomized trial	2020	Zimbabwe	<18 months	Community	IgA (seroconversion)	Weight-for-age	No association	(34)
							Length-for-age	Normal associated with seroconversion
							Weight-for-length	No association
						IgA (seropositivity)	Weight-for-age	Normal associated with seroconversion in univariate model only
							Length-for-age	Normal associated with seroconversion
							Weight-for-length	No association